Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
CA Stock MarketDetailed Quotes
Crescita Therapeutics Inc (CTX)
- 0.760
- 0.0000.00%
15min DelayMarket Closed May 6 16:00 ET
14.15MMarket Cap0.00P/E (TTM)
0.760High0.760Low7.55KVolume0.760Open0.760Prev Close5.74KTurnover0.76052wk High0.05%Turnover Ratio18.61MShares0.40052wk Low--EPS TTM12.24MFloat Cap2.000Historical High0.00P/E (Static)16.11MShs Float0.350Historical Low--EPS LYR0.00%Range %--Dividend TTM0.91P/B1Lot Size--Div Yield TTM
Crescita Therapeutics Inc (CTX) Cash Flow
Quarterly+Annual
YOY
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -60.62%1.07M | -69.77%416K | 176.65%1.17M | -100.55%-3K | -235.71%-513K | 31.26%2.73M | 627.20%1.38M | 239.20%424K | 575.31%547K | -82.26%378K |
| Net income from continuing operations | 96.65%-92K | -338.89%-711K | 172.68%753K | 186.18%798K | -48.88%-932K | -38.47%-2.75M | -8.00%-162K | 19.19%-1.04M | -229.54%-926K | -129.30%-626K |
| Operating gains losses | 959.26%696K | 1,140.63%666K | 150.00%12K | 1,200.00%22K | 44.44%13K | -1,450.00%-81K | -740.00%-64K | -166.67%-24K | ---2K | 80.00%9K |
| Depreciation and amortization | 9.88%1.5M | 12.60%411K | 23.08%384K | 16.12%353K | -8.31%353K | -9.30%1.37M | -3.69%365K | -17.24%312K | -18.93%304K | 2.67%385K |
| Asset impairment expenditure | 102.33%522K | -41.07%33K | 592.16%353K | -9.88%73K | -10.00%63K | -41.10%258K | -64.56%56K | -52.78%51K | -37.21%81K | 62.79%70K |
| Remuneration paid in stock | -60.77%71K | -64.71%6K | -92.13%7K | -48.15%28K | 42.86%30K | 120.73%181K | 180.95%17K | 456.25%89K | -16.92%54K | -4.55%21K |
| Deferred tax | 164.29%9K | ---- | ---- | ---- | ---- | -103.07%-14K | -107.11%-14K | --0 | --0 | --0 |
| Other non cashItems | -1,144.52%-1.82M | -668.66%-381K | -8,783.33%-1.04M | -368.75%-225K | -5.08%-186K | 37.61%-146K | 142.68%67K | 123.53%12K | -328.57%-48K | -276.60%-177K |
| Change In working capital | -95.32%183K | -65.53%383K | -30.78%706K | -197.05%-1.05M | -79.02%146K | 116.32%3.91M | 264.11%1.11M | 5.59%1.02M | 437.69%1.08M | -62.17%696K |
| -Change in receivables | -111.94%-177K | 60.87%-90K | -63.03%383K | -150.43%-644K | 128.95%174K | -59.63%1.48M | -61.97%-230K | -23.88%1.04M | 140.04%1.28M | -131.30%-601K |
| -Change in inventory | -125.68%-558K | -69.95%608K | 83.66%-149K | 39.39%92K | -211.35%-1.11M | 336.97%2.17M | 613.45%2.02M | -35.92%-912K | 6,700.00%66K | 568.46%996K |
| -Change in payables and accrued expense | 99.77%859K | 72.60%-200K | -45.77%481K | -500.00%-450K | 195.40%1.03M | 135.33%430K | -115.98%-730K | 109.20%887K | 92.52%-75K | 216.00%348K |
| -Change in other current assets | 133.91%59K | 35.42%65K | -200.00%-9K | 72.83%-50K | 212.77%53K | -164.21%-174K | -75.63%48K | 106.08%9K | -221.85%-184K | -166.20%-47K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -60.62%1.07M | -69.77%416K | 176.65%1.17M | -100.55%-3K | -235.71%-513K | 31.26%2.73M | 627.20%1.38M | 239.20%424K | 575.31%547K | -82.26%378K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 51.81%-973K | 123.80%84K | -8.89%-821K | 81.36%-170K | -66K | -1,418.05%-2.02M | -236.19%-353K | -2,592.86%-754K | -912K | 0 |
| Net PPE purchase and sale | 69.92%-333K | 85.55%-51K | 93.90%-46K | ---170K | ---66K | -732.33%-1.11M | -236.19%-353K | -2,592.86%-754K | --0 | --0 |
| Net other investing changes | 29.82%-640K | --135K | ---775K | ---- | ---- | ---912K | --0 | ---- | ---912K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 51.81%-973K | 123.80%84K | -8.89%-821K | 81.36%-170K | ---66K | -1,418.05%-2.02M | -236.19%-353K | -2,592.86%-754K | ---912K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 8.48%-788K | 10.42%-215K | -5.29%-239K | -10.76%-175K | 32.63%-159K | -10.10%-861K | 6.98%-240K | 29.94%-227K | -56.44%-158K | -138.38%-236K |
| Net issuance payments of debt | -16.78%-515K | -46.02%-165K | -7.27%-118K | -5.45%-116K | -7.41%-116K | -8.09%-441K | -7.62%-113K | -6.80%-110K | -8.91%-110K | -9.09%-108K |
| Net common stock issuance | 30.31%-223K | --0 | -3.42%-121K | -22.92%-59K | 44.87%-43K | 18.58%-320K | 49.67%-77K | 51.25%-117K | ---48K | ---78K |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other financing activities | 50.00%-50K | ---- | ---- | ---- | ---- | ---100K | ---50K | ---- | ---- | ---50K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 8.48%-788K | 10.42%-215K | -5.29%-239K | -10.76%-175K | 32.63%-159K | -10.10%-861K | 6.98%-240K | 29.94%-227K | -56.44%-158K | -138.38%-236K |
| Net cash flow | ||||||||||
| Beginning cash position | -1.19%9.27M | -1.54%8.31M | -9.19%8.18M | -10.42%8.54M | -1.19%9.27M | 13.92%9.39M | -15.80%8.44M | -11.87%9.01M | -7.24%9.53M | 13.92%9.39M |
| Current changes in cash | -343.87%-688K | -63.60%285K | 120.29%113K | 33.46%-348K | -619.72%-738K | -113.35%-155K | 225.48%783K | -145.37%-557K | -2,515.00%-523K | -93.01%142K |
| Effect of exchange rate changes | -118.60%-8K | -130.77%-16K | 164.71%11K | -250.00%-6K | -25.00%3K | 407.14%43K | 533.33%52K | -177.27%-17K | 113.79%4K | -20.00%4K |
| End cash Position | -7.51%8.58M | -7.51%8.58M | -1.54%8.31M | -9.19%8.18M | -10.42%8.54M | -1.19%9.27M | -1.19%9.27M | -15.80%8.44M | -11.87%9.01M | -7.24%9.53M |
| Free cash from | -51.95%740K | -64.32%365K | 376.23%1.13M | -131.63%-173K | -253.17%-579K | -20.74%1.54M | 379.51%1.02M | -520.62%-408K | 575.31%547K | -82.26%378K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm